PlainRecalls
No agency classActive

CPSC recall · Reported January 26, 2022

Geri-Care Pharmaceuticals Recalls Over-the-Counter Drugs Due to Failure to Meet Child Resistant Packaging Requirement; Risk of Poisoning

The over-the-counter drug products contain regulated substances which must be in child resistant packaging as required by the Poison Prevention Packaging Act (PPPA). The packaging…

Recall #
22060
Affected scope
About 800
Verify with CPSC →
View my saved recalls

Geri-Care Pharmaceuticals, of Brooklyn, New York recalled This recall involves bottles of Geri-Care Brand over-the-counter acetaminophen and aspiri….

Geri-Care Pharmaceuticals Recalls Over-the-Counter Drugs Due to Failure to Meet Child Res… was recalled by Geri-Care Pharmaceuticals, of Brooklyn, New York in January 26, 2022. Reason: The over-the-counter drug products contain regulated substances which must be in child resistant packaging as…. Remedy: Consumers should immediately store the recalled products in a safe location out of sight …. Verify recall #22060 with the CPSC before acting.

The recall

Geri-Care Pharmaceuticals, of Brooklyn, New York issued this CPSC recall-The over-the-counter drug products contain regulated substances which must be in child resistant packaging as….

None
agency class
January 26, 2022
reported

Sourced from official CPSC enforcement records. Verify recall #22060 with the agency before acting. Full product description, hazard, remedy, and related recalls are below.

Recall Insight

This recall's affected scope, documented in the Recall Profile below, stays within a single-region or limited-distribution footprint. Distribution information was not included in the agency filing, so consumers should assume broad potential exposure until the firm publishes point-of-sale details. Consumers holding this product should act on the agency's documented remedy above rather than relying on general guidance.

Within the same product category the archive holds 6 closely related recalls - clustering in a narrow category often points to a systemic quality-control or supplier issue rather than a one-off defect. Always verify the recall number against the official agency record before acting.

Drugs & Medications recalls over time

Where this recall sits in its category - 14,472 drugs & medications recalls on record

05001,0001,5002,000 2006201220152018202120242026 448

Product description

This recall involves bottles of Geri-Care Brand over-the-counter acetaminophen and aspirin. The acetaminophen is 500mg with 1,000 tablets in the bottle. The aspirin was sold in 81mg with 300 and 1,000 tablets in the bottle and 325mg with 250 and 1,000 tablets in the bottle. Product Count Extra Strength Acetaminophen 500mg Tablets 1,000 Regular Strength Enteric Coated Aspirin 325mg Tablets 250 Regular Strength Enteric Coated Aspirin 325mg Tablets 1,000 Adult Low Dose Enteric Coated Aspirin 81mg Tablets 300 Adult Low Dose Enteric Coated Aspirin 81mg Tablets 1,000

Reason for recall

The over-the-counter drug products contain regulated substances which must be in child resistant packaging as required by the Poison Prevention Packaging Act (PPPA). The packaging of the products is not child resistant, posing a risk of poisoning if the contents are swallowed by young children.

Remedy, what to do

Consumers should immediately store the recalled products in a safe location out of sight and reach of children, and safely dispose of the recalled product as soon as is practicable. Contact Geri-Care Pharmaceuticals for a full refund or replacement over-the-counter drug product.

Recall Profile

Structured summary of the CPSC recall record
Attribute Value
Agency U.S. Consumer Product Safety Commission
Severity class Not classified by agency
Status Active
Recall number 22060
Date reported January 26, 2022
Date initiated January 26, 2022
Recalling firm Geri-Care Pharmaceuticals, of Brooklyn, New York
Affected scope About 800
Distribution Not disclosed
Official source CPSC notice →

Profile values are sourced directly from the official CPSC enforcement record. Source: U.S. Consumer Product Safety Commission.

What to do with this recall

Consumers should immediately store the recalled products in a safe location out of sight and reach of children, and safely dispos…

  • Check the recall number (22060) and product description against the item you own. Search the archive
  • Confirm the current status and remedy on the official CPSC notice before acting. CPSC notice
  • Follow the documented remedy (refund, replacement, repair, or disposal) rather than general advice. What to do next

This page summarizes the official CPSC record for research and awareness; it is not legal, medical, or safety advice. Verify with the issuing agency before acting.

Frequently Asked Questions

What product was recalled?
This recall involves bottles of Geri-Care Brand over-the-counter acetaminophen and aspirin. The acetaminophen is 500mg with 1,000 tablets in the bottle. The aspirin was sold in 81mg with 300 and 1,000 tablets in the bottle and 325mg with 250 and 1,000 tablets in the bottle. Product Count Extra Strength Acetaminophen 500mg Tablets 1,000 Regular Strength Enteric Coated Aspirin 325mg Tablets 250 Regular Strength Enteric Coated Aspirin 325mg Tablets 1,000 Adult Low Dose Enteric Coated Aspirin 81mg Tablets 300 Adult Low Dose Enteric Coated Aspirin 81mg Tablets 1,000. Recalled by Geri-Care Pharmaceuticals, of Brooklyn, New York. Units affected: About 800.
Why was this product recalled?
The over-the-counter drug products contain regulated substances which must be in child resistant packaging as required by the Poison Prevention Packaging Act (PPPA). The packaging of the products is not child resistant, posing a risk of poisoning if the contents are swallowed by young children.
What should consumers do?
Consumers should immediately store the recalled products in a safe location out of sight and reach of children, and safely dispose of the recalled product as soon as is practicable. Contact Geri-Care Pharmaceuticals for a full refund or replacement over-the-counter drug product.
Which agency issued this recall?
This recall was issued by the CPSC on January 26, 2022. CPSC does not publish a hazard classification for this recall. Recall number: 22060.
How do I report an injury from a recalled product?
Report injuries to the issuing agency: CPSC at SaferProducts.gov, NHTSA at nhtsa.gov/report-a-safety-problem, or FDA via MedWatch. Document the product (photos, model/serial numbers, purchase receipts) and seek medical attention. Injury reports help agencies track hazard patterns and may strengthen enforcement actions.

Nationwide recalls with similar severity or category timing

Consumer-product notices outside this firm and state, matched by severity timing and product category.

Compare this recall with Kian Pee Wan Capsules, 30-count bottles → · All Drugs & Medications recalls

This recall: CPSC, reported January 26, 2022. Severity classes follow each agency's own taxonomy; related-recall context is computed across the full archive.

Methodology · Corrections · Archive as of August 2026